MYCN and leukemia: Additionally, BI-2536 sensitive SCLC cells statistically exhibited enrichment in c-MYC and MYCN signatures from other cancer types and normal cells, including colorectal, leukemia, lymphoma, blood B cells, and fibroblasts (Figs. 5D and S7A).